Spring Bank Pharmaceuticals, Inc. 4
4 · Spring Bank Pharmaceuticals, Inc. · Filed Feb 27, 2017
Insider Transaction Report
Form 4
Eichler Kurt M
Director
Transactions
- Purchase
Common Stock
2017-02-23$8.76/sh+1,200$10,516→ 1,200 total(indirect: See footnote)
Holdings
- 505,610
Common Stock
- 19,791(indirect: See footnote)
Common Stock
- 10,000(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]The purchase price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.755 to $8.767, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges sent forth in this footnote.
- [F2]These shares are directly held by the Reporting Person as custodian for Katherine Eichler. Katherine Eichler is an immediate family member sharing a household with the Reporting Person.
- [F3]These shares are directly held by Theresa Eichler as custodian for Katherine Eichler. Teresa Eichler and Katherine Eichler are immediate family members sharing a household with the Reporting Person.
- [F4]These shares are directly held by the Kurt M. Eichler Trust Under Agreement dated 12/27/14 FBO Katherine Eichler (the "Katherine Eichler Trust"). The Reporting Person's immediate family member, Katherine Eichler, is a beneficiary of the Katherine Eichler Trust, and the Reporting Person is a trustee of the Katherine Eichler Trust.